1 Min Read
* CANTARGIA RECEIVES PATENT APPROVAL IN CANADA AND BROADENS PROTECTION WITH RESPECT TO HEMATOLOGICAL CANCER Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.